Cargando…
Narrow Band-Ultraviolet B Versus Clobetasol Propionate Foam in the Treatment of Vitiligo: A Retrospective Study
INTRODUCTION: Several therapeutic options are available for the treatment of vitiligo; among these phototherapy and topical steroids are the most widely documented. A topical formulation of 0.05% clobetasol propionate foam (CPF) has been introduced in the market, but no data are available about the...
Autores principales: | Stinco, Giuseppe, Trevisan, Giusto, Buligan, Cinzia, Gregoraci, Giorgia, De Marchi, Sergio, di Meo, Nicola, Patrone, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680636/ https://www.ncbi.nlm.nih.gov/pubmed/23888259 http://dx.doi.org/10.1007/s13555-013-0028-8 |
Ejemplares similares
-
What Is New in Narrow-Band Ultraviolet-B Therapy for Vitiligo?
por: Khanna, Urmi, et al.
Publicado: (2019) -
Efficacy of Tacrolimus Versus Clobetasol in the Treatment of Vitiligo
por: Mumtaz, Hassan, et al.
Publicado: (2020) -
Novel Dermal Delivery Cargos of Clobetasol Propionate: An Update
por: Nair, Anroop B., et al.
Publicado: (2022) -
Seborrheic Pemphigoid
por: Errichetti, Enzo, et al.
Publicado: (2014) -
Clinical and Capillaroscopic Modifications of the Psoriatic Plaque during Therapy: Observations with Oral Acitretin
por: Stinco, Giuseppe, et al.
Publicado: (2013)